C. Alvares

发表

Subtractive Interaction Proteomics Reveal a Network of Signaling Pathways Activated by an Oncogenic Transcription Factor in Acute Myeloid Leukemia

A. Otto, K. Heesom, O. Ottmann, 2018, bioRxiv.

Subtractive Interaction Proteomics Reveal a Network of Signaling Pathways Activated by an Oncogenic Transcription Factor in Acute Myeloid Leukemia

A. Otto, D. Becher, K. Heesom, 2018 .

Isolated Bone Marrow Involvement in Diffuse Large B Cell Lymphoma: A Report of Three Cases with Review of Morphological, Immunophenotypic and Cytogenetic Findings

D. Catovsky, A. Wotherspoon, A. Gruszka-Westwood, 2004, Leukemia & lymphoma.

The role of second autografts in the management of myeloma at first relapse.

G. Morgan, F. Davies, R. Powles, 2006, Haematologica.

Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes

C. Conner, M. Chakraborty, A. Mahdi, 2018, British journal of haematology.

Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation

D. Becher, E. Mehmetbeyoğlu, O. Ottmann, 2022, PLoS genetics.

Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.

G. Morgan, D. Cunningham, F. Dignan, 2006, The Journal of hospital infection.

Combination of a mitogen‐activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion‐based residual disease and prevents re‐expansion of FLT3‐ITD acute myeloid leukaemia

R. Hills, M. Lazenby, A. Burnett, 2020, British journal of haematology.

Long‐term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high‐dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments

G. Morgan, C. Dearden, F. Davies, 2005, British journal of haematology.

Benzene and the hemopoietic stem cell.

G. Morgan, C. Alvares, 2005, Chemico-biological interactions.

The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide – vincristine – doxorubicin – methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis

G. Morgan, M. Jenner, F. Davies, 2006, Leukemia & lymphoma.

A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.

W. Fiedler, J. Edwards, G. Roboz, 2023, Hematological oncology.

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

A. Mead, M. Rozman, N. Cross, 2022, Blood advances.

Tyrosine kinase inhibitor insensitivity of non‐cycling CD34+ human acute myeloid leukaemia cells with FMS‐like tyrosine kinase 3 mutations

G. Morgan, M. Greaves, D. Gonzalez, 2011, British journal of haematology.

Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy

C. Fegan, M. Donia, I. Svane, 2023, Cell.